SRGA - revisions to website documents....
NB. Changes are reported in reversed chronological order. If the change is described only in Swedish this is to signify that the revision is in a part of the document which has no interest outside Sweden.
| Revision and link to revised document
"Major changes" implies
changes that may or will affect susceptibility testing. |
Major change | Minor change | Document revised |
| The nitrofurantoin comment in Enterobacteriaceae footnotes edited. | + | - | 080507 |
| Correction in "Betalactam" MIC- and Zonediameter tables - Comment C): Proteus mirabilis added to E.coli and Klebsiella spp. | + | - | 080427 |
| Correction in the Zone diameter breakpoint table "Miscellaneous": by mistake the nitrofurantoin/Enterobacteriaceae was for E.coli, Citrobacter and K.oxytoca (copy/paste mistake). | + | - | 080403 |
| Notes on daptomycin in both MIC- and Zone diameter tables (MIC-testing only and only on MH) | - | + | 080317 |
| Incubation temperature for cefoxitin on Staphylococci changed from 35 - 36 to 35 C. | + | - | 080314 |
| Fosfomycin preliminary QC-data for the E.coli ATCC-strain | + | - | 080312 |
| Fosfomycintrometamol preliminary zone diameter breakpoints and zone distribution histogram | + | - | 080311 |
| Zone diameter breakpoint table "Miscellaneous antimicrobials" updated with suggested new zone diameter breakpoints. | + | - | 080303 |
| MIC breakpoint tables 1 (cosmetic changes) and 2 updated (finalised EUCAST harmonised breakpoints for all of table 2-antimicrobials). | + | - | 080303 |
| Corrected error (norfloxacin disk screen for FQ resistance in staph and strep - changed from 10/11 to 11/10. | - | + | 080114 |
| Zone diameter breakpoints to correlate with new macrolide breakpoints (20080108). | + | - | 080108 |
| Footnotes on Enterobacteriaceae (S.typhi and Campylobacter) and H.influenzae (macrolide breakpoints) updated to correspond to European harmonised breakpoints. | + | - | 071228 |
| MIC-table for non-betalactam antimicrobials updated with new macrolide breakpoints and with European breakpoints for discussion: miscellaneous and tetracyclines. | + | - | 071228 |
| Zondiameter table 2 (other antimicrobials than betalactams) - screening breakpoints for norfloxacin 10 mcg on staphylococci and streptococci listed in table - not only in footnote. | + | 071108 | |
| Footnote for streptococci and pneumococci - clarifications concerning screen for FQ resistance with norfloxacin. | + | 071108 | |
| Flowchart for ESBL-detection and ESBL-confirmation has been uppdated from Flowchart2005 to Flowchart2007. | + | - | 071104 |
| Makrolider - Europeiska nya brytpunkter på väg. RAFs MIC-tabell jämför de föreslagna nya med de existerande. | |||
| Correction of spelling error in Staphylococcal footnote | - | + | 070706 |
| För att undvika missförstånd i brytpunktstabeller (MIC och Zon) har S.maltophilia tagits bort från överskriften i kolumnen "Pseudomonas/S.maltophilia" - den pekade endast på fotnoten för S.maltophilia. Detta görs nu under tabellerna. | + | - | 070608 |
| New recommendation for fluoroquinolon testing of staphylococci (footnote) | + | - | 070608 |
| Redigering av fluorokinolon-delen av streptokock-fotnoten. Endast språkliga ändringar. | - | + | 070608 |
| En fotnot i zonbrytpunktstabellen (streptokocker och karbapenemer) ledde ingen vart. Det är med dagens rättelse ordnat. | - | + | 070315 |
| E.coli ATCC 25922 - nytt tetracyklin 30 µg lapp intervall. | + | - | 070228 |
| Rättelse i "Minimiprickning" - S.pneumoniae och meningit: testa även meropenem. | - | + | 070918 |
| Gonokock-dokumentet - Örebro meddelar att man fortsättningsvis efter överenskommelse besvarar per telefon, ej per fax. | - | + | 070109 |
| Ertapenem in the zone diameter breakpoint table - disk strength (10 ug) was not given. | - | + | 070109 |
| Ett flertal antibiotika-dokument har uppdaterats avseende resistensmekanismer | - | + | 070108 |
| Zone breakpoint table for betalactams has been updated with new breakpoints following European standardisation (to take effect 2007-01-01). | + | - | 061205 |
| MIC breakpoint table for betalactams has been updated with new breakpoints following European standardisation (to take effect 2007-01-01). | + | - | 061205 |
| H.influenzae and chromosomally mediated penicillin resistance - use a cefaklor disk instead of a lorakarbef disk (breakpoints are the same). The lorakarbef disk can no longer be obtained from Oxoid Ltd. | + | 061124
|
|
| The use of trimethoprim for enterococcal UTI is being discussed (see page 1) - decision will be made together with EUCAST 2007. | (+) | ||
| RAF-M workshop (se första sidan) planeras i Göteborg 30-31 mars, 2007. | + | ||
| "Minimi-prickning" av antibiotika för listeria och meningokocker har uppdaterats. | + | 060830 | |
| Preliminary zone diameter breakpoints for ertapenem. | + | 060830 | |
| Revised zone diameter breakpoints for several antimicrobials and zone diameter breakpoints for tigecycline as a result of European harmonisation. | + | 060830 | |
| Moxifloxacin has received MIC- and zoné breakpoints for staphylococci and streptococci | + | 060830 | |
| Listeria monocytogenes has received new breakpoints (See one of the MIC-tables and the listeria footnote). | + | - | 060830 |
| För daptomycin, tigecyklin och colistin har utarbetats RAF-beskrivningar. | + | - | 060830 |
| RAFs synpunkter på FASS-indikationer för orala och parenterala medel uppdateras under hösten 2006 med början 2006-08-30. | |||
| Alla antibiotikadokument omarbetas under hösten 2006 med början 2006-08-30 | + | - | 060830 |
| Cefixime has been removed from the footnote on staphylococci | - | + | 060628 |
| The section on high-level aminoglycoside resistance in Enterococci has been modified and a comment that may accompany reports on Enterococci in severe infections suggested. | + | - | 060621 |
| The SRGA QC-strains have all been checked and updated. The new ISO-document agreed MIC-ranges for relevant antibiotics have been added. | + | - | 060608
|
| RAF-Ms workshop i Göteborg (22-24 maj, 2006) - programmet har försetts med länkar till presentationer. | |||
| "Minimi-prickning" av antibiotika har uppdaterats - lägg märke till att vi nu också föreslår antibiotika som bör vara med av epidemiologiska skäl! | |||
| The zone diameter breakpoint table for non-betalactam antibiotics has been updated with information on tigecycline and daptomycin. | - | + | 060421 |
| Daptomycin har fått Europeiska MIC-brytpunkter i MIC-tabellen. Lappdiffusion är inte aktuellt för colistin, endast MIC-bestämning. | + | - | 060420 |
| Tigecyklin har fått Europeiska MIC-brytpunkter i MIC-tabellen. Zonbrytpunkter följer. Se även fotnot för Enterobacteriaceae och Anaeroba bakterier. | + | - | 060420 |
| Colistin har fått MIC-brytpunkter i
MIC-tabellen för övriga
medel. Lappdiffusion är inte aktuellt för colistin, endast MIC-bestämning.
Se även fotnot för Enterobacteriaceae. Colistin har beskrivits i RAFs sammanfattningar. |
+ | - | 060420 |
| RAFs värdering av cefalosporiners indikation "samhällsförvärvad intraabdominell infektion" har försetts med en fotnot avseende Pseudomonas och Enterokocker. | - | + | 060420 |
| RAFs värdering av ertapenems indikation "samhällsförvärvad intraabdominell infektion" har ändrats | + | - | 060420 |
| Piperacillin changed to piperacillin/tazobactam (MIC breakpoints for anaerobes) in both MIC breakpoint tables. | + | - | 060328 |
| The Flowcharts on betalactam resistance in Enterobacteriaceae were updated on piperacillin-tazobactam and aztreonam. | + | - | 051114 |
| Footnote Enterobacteriaceae - added a paragraph on mecillinam and ESBL and AmpC | + | - | 050921 |
| Footnote Enterobacteriaceae - added one reference for ESBLs. | - | + | 050830 |
| Nitrofurantoin in MIC- and Zone-diameter tables: breakpoints valid for E.faecalis only, other Enterococci should be designated R without prior testing. | + | 050825 | |
| An attentive user discovered an error on S.lugdunensis in the Staphylococcal footnote to the MIC- and Zone- breakpoint table. The S.lugdunensis breakpoints for cefoxitin shall be 22/21 mm and nothing else. | + | 050429 | |
| Protokoll från senaste RAF-mötet är tillgängligt | + | 050420 | |
| A series of documents (revised 050420 below) on betalactam restsiance and antimicrobial susceptibility testing have been revised during the spring of 2005. Christian Giske has performed the brunt of the work. Many others within the SRGA and SRGA-M have contributed. A special thanks to Arnfinn Sundsfjord, Tromsö, Norway, who has contributed greatly./G Kahlmeter | |||
| General document on betalactam resistance mechanisms and table | + | 050420 | |
| Document on betalactamase detection and characterization revised. | ++ | 050420 | |
| Staphylococcus footnote revised (see cefoxitin testing of CNS). | + | 050420 | |
| Pseudomonas footnote revised. | + | 050420 | |
| Acinetobacter footnote revised. | + | 050420 | |
| Enterobacteriaceae footnote on betalactamase detection and charactareiazation revised. | ++ | 050420 | |
| All texts concerning Enterococcus spp has been updated. However, since the recommendations on antimicrobial susceptibility testing were not changed the documents are not listed separately. | + | 050420 | |
| E.faecalis ATCC 29212 table - the trimethoprim recommended zone diameter range has been changed to 33 - 39 mm. | + | 050216 | |
| Zone diameter breakpoints for Pasteurella multocida and ciprofloxacin (26/22) have been added. | + | 050124 | |
| Data on new disc strengths have been added to QC-strain tables | + | 050104 | |
| On the 1st of January 2005, the european harmonisation of breakpoints for the following classes of drugs will take effect: aminoglycosides, glycopeptides, linezolid and fluoroquinolones. New MIC- and Zonediameter breakpoint tables have been prepared and made available. | ++ | - | |
| Breakpoint tables for PDM-medium and disks for Biodisk have been removed. | + | - | |
| The following disks have been removed from zone breakpoint tables: cefotaxime 30, ceftazidime 30, fusidic acid 50 and ciprofloxacin 10 µg. | ++ | - | |
| Moraxella catarrhalis has now obtained zone diameter breakpoints for trimethoprimsulfamethoxazole | + | 20040804 | |
| Revised breakpoints for the cefoxitin 10 µg-disc for the detection of methicillin resistance in staphylococci (breakpoints in S.aureus increased from S>20 to S>22 mm). Even with difficult hetero-resistant and low-levelresistant strains both sensitivity and specificity are above 99 % (see zone diameter breakpoint tables and Staphylococci footnote). | ++ | 20040610 | |
| Antibiotika i resistensbesked - Stenotrophomonas i urinvägar - korrektion av föreslaget minimiurval. | + | 20040524 | |
| S.pneumoniae vs. oxacillin - a warning concerning oxacillin 1 µg disc testing and MIC-determination is issued. | + | ||
| Stenotrophomonas maltophilia - footnote has been changed and zone diameter distributions for a few antimicrobials have been added. | + | 20040401 | |
| Cefuroxim-axetil - breakpoints for H.influenzae and M.catarrhalis have been removed by SRGA (see the MIC- and Zone diameter tables) | + | 20040401 | |
| Protokoll från senaste RAF-mötet | + | - | |
| Kommentar till fusidinsyra har lagts in i dokumentet Fusidinsyra | - | ||
| Kommentarer till parenterala cefalosporiner har lagts in i respektive dokument. | - | ||
| Kommentarer till kinoloner har lagts in i respektive dokument | - | ||
| See Footnote on Staphylococci - a graph showing S.lugdunensis MIC- and Zone diameter distributions for cefoxitin now available. | |||
| Pseudomonas aeruginosa ciprofloxacin zone diameter breakpoints have been revised; 29/25 for the ciprofloxacin 10 µg disc and 26/22 for the ciprofloxacin 5 µg disc. | 20040304 | ||
| Fusidic acid breakpoints for C.jeikeium and other Corynebacteria removed from tables. Documentation lacking. | 20040304 | ||
| Revised zone diameter breakpoints for Moraxella in zone diameter breakpoint table for non-betalactam antimicrobials. | 20040304 | ||
| Breakpoints Neisseria gonorrhoeae have been updated - Neisseria-tables underneath MIC-tables . | 20040304 | ||
| Ciprofloxacin 5 µg disc will replace the ciprofloxacin 10 µg lapp. Breakpoints and zone diameter distributions for ciprofloxacin 5 µg can now be found in the zone diameter breakpoint table. | |||
| Antimicrobial resistance in N.gonorrhoeae isolated in Sweden - updated 2004-02-17. | - | ||
| In S.aureus, S.pyogenes and in S.pneumoniae - SRGA recommends that strains that exhibit inducible resistance to clindamycin (erythromycin and clindamycin discs next to each other exhibiting a D-shaped clindamycin-zone) are categorized as resistant to both macrolides and clindamycin and that the categorization is accompanied by the comment: "The strain is inducibly resistant to clindamycin" (see footnotes to Staphylococci, Streptococci and S.pneumoniae). | |||
| Anders Österlund, chairman of SRGA, has a new adress and mail-adress. | 20040208 | ||
| Cefpirome has been removed from the Swedish market and is therefore removed from MIC- and zonediameter tables. | - | ||
| RAF:s beskrivningar av respektive antibiotikum förses successivt med en sammanfattande karakteristik av varje medel. Kommentarerna för fluoroquinoloner har just färdigställts utgör nu en del av respektive beskrivning. | 20040205 | ||
| Antimicrobial resistance in Neisseria gonorrhoeae isolated in Sweden is now available on the web-pages. | - | ||
| H.influenzae ATCC 8468 has received a QC-range for the nalidixic acid 30 µg disc (33 - 39 mm) and ranges for some of the other discs have been validated (and in teo instances revised) following the change of medium 2003 (from IsoVitalex to NAD) | 20040118 | ||
| H.influenzae and fluoroquinolone resistance is as yet very unusual. A screen-test based on the nalidixic acid 30 µg disc on medium B has been developed and breakpoints (25/24 mm) to screen for fluoroquinolone resistance determined. | 20031230 | ||
| Two new disc strengths (cefotaxime 5 and ceftazidime 10) have been added to the zone diameter breakpoint table for Oxoid´s medium and discs. | 20031230 | ||
| Zonbrytpunkterna för levofloxacin och Stafylokocker hade i sb m en redigering av misstag ändrats - de är nu ändrade tillbaka till 40/18 mm. | 20031218 | ||
| Metoden för resistensbestämning av Neisseria gonorrhoeae har uppdaterats av RAF (den vid RAF-M-mötet i Göteborg 2003 överenskomna metoden beskrivs) och av Neisserialaboratoriet i Örebro. | 20031125 | ||
| A novel search engine has been included in the SRGA homepage. The search is effected from the first page (www.srga.org) and down which means that only hits within the SRGA homepages are presented. | - | ||
| The recommended methodology for the use of a cefoxitin 10 µg disc for the detection of MRSA and MRSE is now available on the SRGA homepages. See betalactam zone diameter breakpoint tables (ISA and PDM) and the footnote for Staphylococci. Distributions are available from both. QC-recommendations are available for S.aureus ATCC 29213. | 20031109 | ||
| Protokoll från RAF´s och RAF-M´s 2-dagarsmöte i Smygehuk, 2003, finns nu tillgängligt. | - | ||
| RAF:s synpunkter på godkända indikationer för såväl orala som parenterala antibiotika har uppdaterats och reviderats (kinoloner, cefalosporiner, övriga medel) bl.a. med synpunkter på linezolid och moxifloxacin. | 031109 | ||
| Tetracycline zone daimeter breakpoints have been given for Yersinia enterocolitica - see zone diameter breakpoint tables. | 030904 | ||
| The document on "Quality assurance" has been relocated to "SRGA methods for susceptibility testing of bacteria" | 030904 | ||
| Antibiotika i resistensbesked -RAF:s rekommenderade minimiuppsättning reviderat av RAF och RAF-M 2003-09-01. | 030904 | ||
| E.faecalis and E.faecium are poor targets for karbapenems and with one exception (imipenem and E.faecalis) their karbapenem breakpoints have been removed (see MIC- and Zone-diameter tables). | 030904 | ||
| Staphylococci and Fusidic acid - the 50 ug disc has been exchanged for the 10 ug-disc (see zonebreakpoint tables) | 030904 | ||
| S.agalactiae (GBS) and trimethoprim - the SRGA has decided that S.agalactiae is a poor target for trimethoprim therapy. Both MIC- and zone-diameter breakpoints have been deleted (see MIC- and Zonebreakpoint tables) | 030904 | ||
| Species-related considerations (footnotes to MIC- and zonebreakpoint tables) are now available as links from the page on methodology. | 030813 | ||
| The recipee for Medium B (defibrinated horse blood plus beta-NAD) has been updated with information on suppliers of beta-NAD. We have had reports that not all beta-NAD gives the same excellent growth of H.influenzae as the beta-NAD from Mast Diagnostics and ICN. | 030813 | ||
| Document and table on betalactamase have been revised. | 030813 | ||
| On the page "SRGA methodology" a link has been placed to "Species related methodological considerations", i.e. a comprehensive table listing all the methodological footnotes which can also be reached from the MIC- and Zone-diameter breakpoint tables. | - | ||
| Inducible macrolide resistance: classify isolates as R to all macrolides and clindamycin. | 030407 | ||
| Många antibiotikadokument har förnyats avseende kapitlet "farmakodynamik" | 03040 | ||
| New SRAM (Swedish Reference Group of Antimycotics) -website for antifungals. | |||
| MIC-tables (betalactams and other
antibiotics) have been changed - breakpoints now expressed as S<X
mg/L and R>Y mg/L (rather than the previous R>Y mg/L). The change does not affect Zone diameter breakpoint tables for the time being - zone diameter are continuous variables as opposed to MIC:s which are discontinuous variables. |
|||
| Zone breakpoint tables (PDM och ISA) have been changed for vancomycin och teicoplanin. | 030405 | ||
| RAF:s workshop i Göteborg 27-28/3, 2003. Program och material utlagt! | fortlöpande | ||
| QC with reference strains: The links to CCUG were incorrect for a while. Fixed! | 030326 | ||
| Penicillin G and V discs from Oxoid contains 10 U (corresponding to 6 µg) of penicillin. All data and breakpoints presented for the Oxoid penicillin discs pertain to these disc strengths (see Zone diameter breakpoint table for Oxoid material) | 021112 | ||
| Correction concerning both MIC breakpoint tables: The medium recommended for Corynebacterium spp should read Medium B (as it does in the zonediameter breakpoint tables and in the section on methodology (footnote to Corynebacteria) ). | 021017 | ||
| Enterobacteriaceae and quinolone resistance - data from Lund added to back ground material | - | ||
| Ertapenem - RAF:s beskrivning av ertapenem finns nu tillgänglig | - | ||
| Ertapenem has received MIC-breakpoints (zone diameter breakpoints pending further testing) | - | ||
| The Swedish Antimicrobial Resistance Surveillance Network (ResNet) is now available on the web. Clinical laboratories have received appropriate codes for registration of results. The public is invited to utilize the database through "search database". | - | ||
| The document "Quality assurance" has been re-written following a discussion with Swedish microbiology and the Swedish institute for ackreditation, Swedac. The document now contains a section for calibrating the method. Furthermore, all tables of the SRGA official QC-strains have new data. | 020603 | ||
| Cefixims aktivitet mot stafylokocker anges fortsättningsvis som otillräcklig (se RAF:s beskrivning av Cefixim, Fotnot till Stafylokocker i MIC- och zontabeller samt FASS) | 020530 | ||
| Från Örebro har resistenssiffror för Meningokocker och Gonokocker uppdaterats i fotnoterna. | 020219 | ||
| The Biodisk linezolid zone diameter breakpoint has been decreased by 2 mm (to 21/17 mm instead of 23/19 mm) since a cross-over study has shown that irrespective of species the Biodisk disk linezolid 10 µg gives a 2 mm smaller zone diameter than the corresponding Oxoid disk | 011214 | ||
| Missing link from aminoglycoside breakpoints in MIC-table corrected | 011008 | ||
| Ciprofloxacin and Stenotrophomonas maltophilia. When Pseudomonas obtained new zone diameter breakpoints for ciprofloxacin the SRGA forgot to make a note that Stenotrophomonas maltophilia retains the old breakpoint S/R: 23/19 mm. | 010925 | ||
| Linezolid zone diameter distributions (24 laboratories) linked from the zone breakpoint table | - | ||
| Sammanställning av N.gonorrhoeae 2000 - material från Per Olcén. | - | ||
| Inbjudan till och program för RAF-M-dag 19 november, 2001 | - | ||
| New recommendations for quinolone susceptibility testing in Enterobacteriaceae are in the MIC-breakpoint table and in the Enterobacteriaceae footnote. Ciprofloxacin and other quinolone zone diameter breakpoints have been changed (Oxoid and Biodisk). | 010903 | ||
| Linezolid, dalfopristine/quinupristine and telitromycin are now in the zone breakpoint tables (Oxoid and Biodisk). | 010903 | ||
| Nya antibiotika - RAF:s beskrivningar (Linezolid, Dalfopristin/Quinupristin, Telitromycin) | - | ||
| Zone breakpoint tables (Oxoid and Biodisk) have been supplemented with new antibiotics (see MIC-tables below); zone breakpoints will be added within 2 weeks. To the Oxoid table has been added zone distribution Enterobacteriaceae data on the nalidixic acid 30 µg disk which shortly will be recommended as the Enterobacteriaceae screen disk for quinolone resistance. | 010823 | ||
| Three antibiotics have been added to the MIC breakpoint table: Linezolid, Telitromycin and Dalfopristine/Quinupristine. | 010823 | ||
| Norfloxacin and Ofloxacin - breakpoints for Pseudomonads have been removed. It is recommended that both drugs are avoided for Pseudomonas infections and that susceptibility testing should be performed against more active quinolones. | 010823 | ||
| Samtliga "RAF's sammanfattningar av ...de fem aktuella kinolonerna" har erhållit ett uppdaterat stycke avseende resistens | 010513 | ||
| The species-related teicoplanin MIC-breakpoint for enterococci was shown to be superfluous and has ben removed. | 010504 | ||
| Enterococci - footnote now includes suggestions for easy identification of E.faecalis, E.faecium, E.casseliflavus and E.gallinarum. | 001219 | ||
| A clarification on susceptibility testing of H.influenzae against betalactams: see: " - Penicillin V (10 µg) £ 15 mm and/or loracarbef (30 µg) £ 22 mm " - the "and" has been changed to"and/or". | 001208 | ||
| Breakpoints for doxycycline have been removed from MIC- and Zone-diameter tables. This is to avoid the use of doxycyline substance in tetracycline susceptibility testing - always use tetracycline. | 001129 | ||
| QC-resultatet för Stafylokocker, Enterobacteriaceae och enterokocker är nu utlagda på Sunne-sidan | - | ||
| The Neisseria gonorrhoeae-document has been revised by the Neisseria-laboratory in Örebro | 001115 | ||
| S.aureus footnotes and methodology - revised in total. | 001026 | ||
| Mupirocin S.aureus zonediameter histograms and tentative breakpoints for a 5 and 10 µg disc. | 000706 | ||
| Moxifloxacin MIC- och Zonediameter breakpoints and MIC-distributions | - | ||
| Moxafloxacin- RAF:s sammanfattning | - | ||
| The footnote on H.influenzae has been revised. The revision does influence methodological aspects. | 000502 | ||
| The footnote on Corynebacterium has been revised and translated to english. | 000425 | ||
| Antibiotika i resistensbestämning (minimiuppsättning) - reviderad efter genomgång i RAF-M | 000419 | ||
| Enterobacteriaceae footnote has been updated on tetracycline. | 000417 | ||
| Cefepime has now received zone breakpoints also for Oxoid material. | - | ||
| Dokumenten Gentamicin, Tobramycin, Amikacin & Netilmicin har alla under "Otillräcklig aktivitet" fått tillägget Pasteurella. | 000416 | ||
| The Helicobacter footnote has been revised - new data on resistance was included. | 000416 | ||
| The penicillin V MIC-breakpoints for P.multocida (see below MIC-breakpoint tables) had erronously been given as 0.5/8 mg/L - correct value: 0.5/1 mg/L. | 000416 | ||
| Footnote on P.multocida (see below MIC-breakpoint tables) has been revised. The activity of some of the antibiotics has been commented upon. The use of medium C and the CO2-atmosphere were clarified. | 000416 | ||
| Footnote to Tables (MIC- and Zonebreakpoints) on "Enterococci" has been revised - PYR-test on enterococci included and the poor activity of meropenem egainst all enterococci is pointed out. | 000416 | ||
| "RAF:s kommentarer till godkända indikationer" för penicilliner - ett tillägg efter "Infektioner i skelett och leder" resp "Infektioner i lungor" - i båda fallen med tillägget " orsakade av Staphylococcus aureus. | 000401 | ||
| RAF:s sammanfattningar uppdaterade med Indikationstexterna ur FASS 2000. | 000327 | ||
| RAF:s synpunkter på godkända indikationer har reviderats februari, 2000 | 000304 | ||
| QC with reference strains: The links to CCUG were incorrect for a while. Fixed! | 000214 | ||
| The interpretation of the PBP-type betalactam-resistance in H.influenzae has been clarified. | 000210 | ||
| Cefpirome zone diameter breakpoints added to the Oxoid table | 000126 | ||
| Raxar (Grepafloxacin) är indraget av Glaxo pga biverkningar - mer information följer! | - | ||
| Antibiotikakompendiet är nu uppdaterat. | 990928 | ||
Table revised 2008-05-07, by gunnar.kahlmeter@ltkronoberg.se
